IXHL
Incannex Healthcare, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$2.54
−1.55%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-28.6%
Return on equity
-26.4%
Return on assets
-34.1%
Return on invested capital
0.00x
Asset turnover
-$12.9M
Cash from operations
$5.40
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026